| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 10/06/2004 | CN1169544C Fracture-setting silky fowl ointment and its prepn |
| 10/06/2004 | CN1169541C Medicine for treating rheumatoid arthritis |
| 10/06/2004 | CN1169532C Liquor for treating rheumatism and arthritis |
| 10/05/2004 | US6800659 Compounds for modulating cell proliferation |
| 10/05/2004 | US6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 10/05/2004 | US6800653 Anticancer agents |
| 10/05/2004 | US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc. |
| 10/05/2004 | US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 10/05/2004 | US6800613 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 10/05/2004 | US6800605 With a hypolipidemic agent, an antidiabetic agent, an antidepressant, a bone resorption inhibitor, an appetite suppressant and/or an anti-obesity agent |
| 10/05/2004 | US6800446 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 10/02/2004 | CA2444359A1 Artificial cartilage |
| 09/30/2004 | WO2004083434A1 A combined adeno-associated virus and adenovirus cocktail gene delivery system for high effiency gene expression without eliciting immune response in immuno-competent subjects |
| 09/30/2004 | WO2004083414A1 Monocyte-origin multipotent cell momc |
| 09/30/2004 | WO2004083364A2 Cell preparation and use of the preparation for treating joints and cartilage defects, and methods for the production thereof |
| 09/30/2004 | WO2004083257A1 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 09/30/2004 | WO2004083188A1 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 09/30/2004 | WO2004083185A2 Phenyl substituted imidazole derivatives |
| 09/30/2004 | WO2004083184A1 Receptor antagonist |
| 09/30/2004 | WO2004082705A1 Treatment of dupuytren’s contracture |
| 09/30/2004 | WO2004082704A1 Method of treating inflammtory disease associated with bone destruction |
| 09/30/2004 | WO2004082608A2 Ligands for tgf-beta binding proteins and uses thereof |
| 09/30/2004 | WO2004082580A2 Photostabilized topical formulations of ketoprofen containing two uv filters |
| 09/30/2004 | WO2004069266A3 Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis |
| 09/30/2004 | WO2003097806A3 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/30/2004 | WO2003080105A9 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 09/30/2004 | US20040194159 Cloning pigs using donor nuclei from differentiated cells |
| 09/30/2004 | US20040192943 Nf-kappab inhibitors |
| 09/30/2004 | US20040192914 Compounds and methods |
| 09/30/2004 | US20040192779 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 09/30/2004 | US20040192742 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; glomerulonephritis; malaria; oral diseases |
| 09/30/2004 | US20040192733 Hydroxamic acid derivatives |
| 09/30/2004 | US20040192720 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 09/30/2004 | US20040192716 Mixture with 2-amino-1,3-propanediol and excipients; synergistic mixture; concurrent administering |
| 09/30/2004 | US20040192701 Phenlypyridine carbonyl piperazine derivative |
| 09/30/2004 | US20040192685 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 09/30/2004 | US20040192673 Obesity, non-insulin-dependent diabetes,strokes, sleep disorders; antiischemic and antiemetic agents |
| 09/30/2004 | US20040192670 For inhibiting bone resorption, treating/preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, aniogenesis, atherosclerosis, arthritis, tumor growth and metastasis |
| 09/30/2004 | US20040192605 Methods and compositions for healing and repair of articular cartilage |
| 09/30/2004 | US20040191826 Dipeptidyl peptidases |
| 09/30/2004 | US20040191344 Pharmaceutical composition for prophylaxis or treatment of osteoporosis, and method to prepare the same |
| 09/30/2004 | US20040191210 Compounds |
| 09/30/2004 | CA2519414A1 Methods of treating inflammatory diseases associated with bone destruction |
| 09/30/2004 | CA2519131A1 Ligands for tgf-beta binding proteins and uses thereof |
| 09/30/2004 | CA2518227A1 Water-soluble phenylpyridazine derivative and medicine containing the same |
| 09/29/2004 | EP1462449A1 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha levels |
| 09/29/2004 | EP1462108A1 Interferon g (g) production promoter |
| 09/29/2004 | EP1461614A2 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 09/29/2004 | EP1461443A2 Carbohydrate-associated proteins |
| 09/29/2004 | EP1461358A1 Ifnar2 muteins, their production and use |
| 09/29/2004 | EP1461334A2 Pyrazole derived kinase inhibitors |
| 09/29/2004 | EP1461333A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461327A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461325A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/29/2004 | EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 09/29/2004 | EP1461313A1 Human adam-10 inhibitors |
| 09/29/2004 | EP1461165A1 Metallic structures incorporating bioactive materials and methods for creating the same |
| 09/29/2004 | EP1461086A2 Enzymatic cleavable reagents for specific delivery to disease sites |
| 09/29/2004 | EP1461043A1 Oral pharmaceutical products containing 17 beta-estradiol-3 lower alkanoate, method of administering the same and process of preparation |
| 09/29/2004 | EP1461031A2 Formulations for oral administration of cromolyn sodium |
| 09/29/2004 | EP1461021A1 Transdermal drug delivery system of strychnine, brucine, securinine and their salts |
| 09/29/2004 | EP1460969A2 Prevention and treatment of androgen-deprivation induced osteoporosis |
| 09/29/2004 | EP1385874A4 Alpha conotoxin peptides with analgesic properties |
| 09/29/2004 | EP1303527B1 Matrix metalloproteinase inhibitors |
| 09/29/2004 | EP1299350B1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness |
| 09/29/2004 | EP1210320B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/29/2004 | EP1202959B1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
| 09/29/2004 | EP1202957B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/29/2004 | EP1189881B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/29/2004 | EP1181278B1 Cyclic amine derivatives and their uses |
| 09/29/2004 | EP1169302B1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
| 09/29/2004 | EP1153015B1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 09/29/2004 | EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases |
| 09/29/2004 | CN1533399A 免疫调节肽 Immunomodulatory peptides |
| 09/29/2004 | CN1533392A Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |
| 09/29/2004 | CN1533391A Tricyclic compounds and their uses |
| 09/29/2004 | CN1533388A Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
| 09/29/2004 | CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 09/29/2004 | CN1533279A Organo-phosphorous compounds for activating gamma/delta T-cells |
| 09/29/2004 | CN1533275A Use of 4-[(4-thiazolyl) phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis |
| 09/29/2004 | CN1533270A Oral administered dosage form of GABA anolog prodrugs having reduced toxicity |
| 09/29/2004 | CN1531965A Medicinal wine for dredging channels, subduing swelling and stopping pain |
| 09/29/2004 | CN1531964A Chinese medicine plaster for treating protrusion of lumber interverte bral disc |
| 09/29/2004 | CN1531950A Plaster medicine composition with multiple purpose for treating affection pain due to dampness |
| 09/29/2004 | CN1531944A Fumula and production process of medicine for treating gout |
| 09/29/2004 | CN1531938A Chinese medicine preparation for treating necrosis of femoral head |
| 09/29/2004 | CN1531932A Prepn process and formula of compound chondroitin sulfate tablet |
| 09/29/2004 | CN1531925A Process for preparing colatemo solid preparation and its solid preparation |
| 09/29/2004 | CN1168738C Biotin derivatives |
| 09/29/2004 | CN1168727C Substituted benzimidazole |
| 09/29/2004 | CN1168726C Novel vitamin D analogues |
| 09/29/2004 | CN1168721C 5-cyano-2-aminopyrimidine derivatives |
| 09/29/2004 | CN1168720C Aryl alkanoylpyridazines compounds |
| 09/29/2004 | CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use |
| 09/29/2004 | CN1168494C Injection-type compound bone repairing material containing more biological factors and using animal fibrin as carrier |
| 09/29/2004 | CN1168479C Ointment for curing rheumatism and osteoarthropathy |
| 09/29/2004 | CN1168477C Capsule for curing neck and waist diseases and its preparing process |